1 to 9 of 20 results

Sun Pharma’s takeover of Ranbaxy comes to attention of Competition Commission

Sun Pharma’s takeover of Ranbaxy comes to attention of Competition Commission


The deal between Indian generics company Sun Pharmaceutical Industries which acquired fellow Indian drug…

CCIGenericsIndiaMergers & AcquisitionsPharmaceuticalRanbaxy LaboratoriesSun Pharmaceutical Industries

Forest Labs files law suit against several drugmakers for Namenda XR patent infringement


US drugmaker Forest Laboratories, together with Merz Pharma and Adamas Pharmaceuticals, has filed a law…

Adamas PharmaceuticalsForest LaboratoriesLegalMerz PharmaceuticalsNamendaNeurologicalNorth AmericaPatentsPharmaceuticalSun Pharmaceutical IndustriesTeva Pharmaceutical IndustriesUSAWockhardt

Sun Pharma sets up JV with Intrexon for ocular diseases


Sun Pharmaceutical Industries and Intrexon Corp have formed a joint venture to develop controllable gene-based…

IntrexonPharmaceuticalResearchSun Pharmaceutical Industries

Pfizer in $2.15 billion settlement from Teva and Sun for infringement of Protonix patent


Global pharma behemoth Pfizer (NYSE: PFE) today (June 12) said it has reached a $2.15 billion settlement…

Gastro-intestinalsGenericsLegalNorth AmericaPatentsPfizerPharmaceuticalProtonixSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

Briefs: Depomed drops Sefelsa after CRL: Sun Pharma stalking Meda?


US specialty drugmaker Depomed (Nasdaq: DEPO) says that Food and Drug Administration issued a complete…

DepomedMedaMergers & AcquisitionsMetabolicsNorth AmericaPharmaceuticalRegulationResearchSefelsaSun Pharmaceutical Industries

Sun Pharma gives up fight to take full control of Taro; Angel Biotech in administration


Israel-based Taro Pharmaceutical Industries (Pink Sheets: TAROF) and Indian drugmaker Sun Pharmaceutical…

Angel BiomedicalAngel BiotechnologyBiotechnologyFinancialMergers & AcquisitionsPharmaceuticalSun Pharmaceutical IndustriesTaro Pharmaceuticals

Takeda sells non-Colcrys URL Pharma generic business to Sun Pharma; Eisai divests Gliadel Wafer in USA


Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502), has entered into a definitive agreement…

Arbor PharmaceuticalsColcrysEisaiGenericsGliadelMergers & AcquisitionsNorth AmericaOncologyPharmaceuticalSun Pharmaceutical IndustriesTakeda PharmaceuticalsURL Pharma

Sun Pharma to acquire DUSA Pharmaceuticals for $230 million


India's Sun Pharmaceutical Industries (SUN.BO) has entered into a definitive agreement to acquire US…

DermatologicalsDUSA PharmaceuticalsLevulanMergers & AcquisitionsPharmaceuticalSun Pharmaceutical Industries

1 to 9 of 20 results



Back to top